| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2421727
[patent_doc_number] => 04738845
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-04-19
[patent_title] => 'Modified (115-145) beta interferons'
[patent_app_type] => 1
[patent_app_number] => 6/623894
[patent_app_country] => US
[patent_app_date] => 1984-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5949
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/738/04738845.pdf
[firstpage_image] =>[orig_patent_app_number] => 623894
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623894 | Modified (115-145) beta interferons | Jun 24, 1984 | Issued |
Array
(
[id] => 2171433
[patent_doc_number] => 04537858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-08-27
[patent_title] => 'Plastatin'
[patent_app_type] => 1
[patent_app_number] => 6/623306
[patent_app_country] => US
[patent_app_date] => 1984-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2093
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/537/04537858.pdf
[firstpage_image] =>[orig_patent_app_number] => 623306
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623306 | Plastatin | Jun 21, 1984 | Issued |
Array
(
[id] => 2421709
[patent_doc_number] => 04738844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-04-19
[patent_title] => 'Modified (1-28) beta interferons'
[patent_app_type] => 1
[patent_app_number] => 6/623814
[patent_app_country] => US
[patent_app_date] => 1984-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7910
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/738/04738844.pdf
[firstpage_image] =>[orig_patent_app_number] => 623814
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623814 | Modified (1-28) beta interferons | Jun 21, 1984 | Issued |
Array
(
[id] => 2386872
[patent_doc_number] => 04793995
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-12-27
[patent_title] => 'Modified (1-56) beta interferons'
[patent_app_type] => 1
[patent_app_number] => 6/623815
[patent_app_country] => US
[patent_app_date] => 1984-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10867
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/793/04793995.pdf
[firstpage_image] =>[orig_patent_app_number] => 623815
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623815 | Modified (1-56) beta interferons | Jun 21, 1984 | Issued |
Array
(
[id] => 2386020
[patent_doc_number] => 04753795
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-06-28
[patent_title] => 'Modified (80-113) beta interferons'
[patent_app_type] => 1
[patent_app_number] => 6/623601
[patent_app_country] => US
[patent_app_date] => 1984-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7567
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/753/04753795.pdf
[firstpage_image] =>[orig_patent_app_number] => 623601
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623601 | Modified (80-113) beta interferons | Jun 21, 1984 | Issued |
Array
(
[id] => 2268836
[patent_doc_number] => 04584195
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-04-22
[patent_title] => 'Broad spectrum vaccine against gonorrhea'
[patent_app_type] => 1
[patent_app_number] => 6/623178
[patent_app_country] => US
[patent_app_date] => 1984-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4176
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/584/04584195.pdf
[firstpage_image] =>[orig_patent_app_number] => 623178
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/623178 | Broad spectrum vaccine against gonorrhea | Jun 20, 1984 | Issued |
Array
(
[id] => 2416247
[patent_doc_number] => 04748018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-05-31
[patent_title] => 'Method of passive immunization of mammals using avian antibody'
[patent_app_type] => 1
[patent_app_number] => 6/622130
[patent_app_country] => US
[patent_app_date] => 1984-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6302
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/748/04748018.pdf
[firstpage_image] =>[orig_patent_app_number] => 622130
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/622130 | Method of passive immunization of mammals using avian antibody | Jun 18, 1984 | Issued |
Array
(
[id] => 2167450
[patent_doc_number] => 04540683
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-09-10
[patent_title] => 'In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound'
[patent_app_type] => 1
[patent_app_number] => 6/621796
[patent_app_country] => US
[patent_app_date] => 1984-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 8616
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/540/04540683.pdf
[firstpage_image] =>[orig_patent_app_number] => 621796
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/621796 | In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound | Jun 17, 1984 | Issued |
| 06/617483 | ANTIGENIC PROTEINS AND VACCINES CONTAINING THEM AND PROTECTIVE ANTIBODIES DIRECTED TO THEM FOR PREVENTION OF COCCIDIOSIS CAUSED BY EIMERIA TENELLA AND EIMERIA NECATRIX | Jun 4, 1984 | Abandoned |
| 06/614130 | POLYPEPTIDE HAVING GAMMA-INTERFERON ACTIVITY LACKING AMINO ACIDS CODED BY EXON 4 | May 24, 1984 | Abandoned |
Array
(
[id] => 2323038
[patent_doc_number] => 04680174
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-07-14
[patent_title] => 'Induction of immune response by immunization with encapsulated antigen-producing cells'
[patent_app_type] => 1
[patent_app_number] => 6/613803
[patent_app_country] => US
[patent_app_date] => 1984-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6919
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/680/04680174.pdf
[firstpage_image] =>[orig_patent_app_number] => 613803
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/613803 | Induction of immune response by immunization with encapsulated antigen-producing cells | May 23, 1984 | Issued |
| 06/606307 | PSEUDORABIES VIRUS (PRV) PROTEIN | May 1, 1984 | Abandoned |
Array
(
[id] => 2355876
[patent_doc_number] => 04687664
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1987-08-18
[patent_title] => 'Method of inactivating reproducible pathogens'
[patent_app_type] => 1
[patent_app_number] => 6/605658
[patent_app_country] => US
[patent_app_date] => 1984-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6193
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/687/04687664.pdf
[firstpage_image] =>[orig_patent_app_number] => 605658
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/605658 | Method of inactivating reproducible pathogens | Apr 29, 1984 | Issued |
Array
(
[id] => 2393005
[patent_doc_number] => 04769326
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-09-06
[patent_title] => 'Expression linkers'
[patent_app_type] => 1
[patent_app_number] => 6/599464
[patent_app_country] => US
[patent_app_date] => 1984-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/769/04769326.pdf
[firstpage_image] =>[orig_patent_app_number] => 599464
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/599464 | Expression linkers | Apr 11, 1984 | Issued |
Array
(
[id] => 2383393
[patent_doc_number] => 04783402
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-11-08
[patent_title] => 'Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique'
[patent_app_type] => 1
[patent_app_number] => 6/598697
[patent_app_country] => US
[patent_app_date] => 1984-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17383
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 502
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/783/04783402.pdf
[firstpage_image] =>[orig_patent_app_number] => 598697
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/598697 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | Apr 9, 1984 | Issued |
Array
(
[id] => 2391893
[patent_doc_number] => 04782019
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-11-01
[patent_title] => 'Enzymatic production of sphingophospholipid derivatives'
[patent_app_type] => 1
[patent_app_number] => 6/598696
[patent_app_country] => US
[patent_app_date] => 1984-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11307
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/782/04782019.pdf
[firstpage_image] =>[orig_patent_app_number] => 598696
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/598696 | Enzymatic production of sphingophospholipid derivatives | Apr 9, 1984 | Issued |
| 06/597115 | VACCINE AND SERUM FOR ENDOTOXIN ASSOCIATED DISEASE IMMUNIZATION AND TREATMENT | Apr 4, 1984 | Abandoned |
Array
(
[id] => 2420953
[patent_doc_number] => 04762705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-08-09
[patent_title] => 'Cancer therapy with interferon'
[patent_app_type] => 1
[patent_app_number] => 6/594436
[patent_app_country] => US
[patent_app_date] => 1984-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1764
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/762/04762705.pdf
[firstpage_image] =>[orig_patent_app_number] => 594436
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/594436 | Cancer therapy with interferon | Mar 28, 1984 | Issued |
Array
(
[id] => 2441272
[patent_doc_number] => 04751081
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-06-14
[patent_title] => 'Chitinase-producing bacteria'
[patent_app_type] => 1
[patent_app_number] => 6/593691
[patent_app_country] => US
[patent_app_date] => 1984-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7168
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/751/04751081.pdf
[firstpage_image] =>[orig_patent_app_number] => 593691
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/593691 | Chitinase-producing bacteria | Mar 25, 1984 | Issued |
| 06/593339 | LTR MODIFIED VIRAL VACCINES | Mar 25, 1984 | Abandoned |